Treatment of Candida krusei in Urinary Tract Infections
For Candida krusei urinary tract infections, amphotericin B deoxycholate at a dose of 0.3-0.6 mg/kg daily for 1-7 days is the recommended first-line treatment. 1
Primary Treatment Approach
Amphotericin B deoxycholate therapy:
- Dosage: 0.3-0.6 mg/kg daily
- Duration: 1-7 days
- Strong recommendation with low-quality evidence 1
Adjunctive measures:
Alternative local therapy option:
Special Considerations
Why fluconazole is not an option:
C. krusei exhibits intrinsic resistance to fluconazole, making this common antifungal ineffective 3, 4.
Limitations of other antifungals:
- Echinocandins (e.g., caspofungin, micafungin) and newer azoles (voriconazole, posaconazole) generally achieve poor urinary concentrations and are not recommended for uncomplicated fungal UTIs 2, 4
- However, in complex cases with tissue invasion or in transplant recipients where amphotericin B is contraindicated due to toxicity concerns, higher-dose echinocandins may be considered as demonstrated in case reports 3
Treatment approach based on infection severity:
For asymptomatic candiduria:
For symptomatic cystitis:
- Amphotericin B deoxycholate as outlined above 1
For pyelonephritis:
- Same treatment as cystitis with focus on eliminating obstruction 1
For fungal balls or abscesses:
Common Pitfalls to Avoid
- Using fluconazole for C. krusei infections (intrinsic resistance)
- Failing to remove indwelling catheters when feasible
- Not addressing underlying urinary tract obstruction
- Using antifungals with poor urinary concentrations (echinocandins, newer azoles) as primary therapy
- Treating asymptomatic candiduria in low-risk patients
- Not distinguishing between colonization and true infection
Monitoring and Follow-up
- Assess clinical improvement of symptoms
- Obtain follow-up urine cultures to confirm eradication
- Continue treatment until symptoms resolve and cultures become negative
- Consider surgical intervention for persistent infections or fungal balls
In refractory cases or patients with contraindications to amphotericin B, consultation with infectious disease specialists is warranted to consider alternative approaches such as higher-dose echinocandins in special circumstances 3.